NDUFS5P3

Across TCGA pan-cancer cohorts, NDUFS5P3 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated NDUFS5P3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher NDUFS5P3 RNA is associated with better overall survival. In most high-consensus cancer types, elevated NDUFS5P3 expression acts as an unfavorable survival marker, although some lineages such as STAD and BLCA show a favorable association.

STAD, ESCA, and BLCA are the cancer types where NDUFS5P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Quartile	II,III,IV	0.785	0.549	.001	35	view →
ESCA	OS	Quartile	II,III,IV	0.348	0.651	.011	30	view →
BLCA	OS	Tertile	All	0.774	0.519	.017	26	view →
SKCM	OS	Tertile	All	0.856	0.760	.002	24	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
UCS	OS	Median	IV	0.240	0.615	.027	18	view →
PCPG	DFS	Tertile	All	1.000	0.749	.038	9	view →
READ	OS	Tertile	All	0.732	0.930	.022	9	view →
LIHC	OS	Tertile	II,III,IV	0.545	0.721	.033	9	view →
THCA	DFS	Tertile	IV	0.717	0.964	.029	9	view →
DLBC	DFS	Quartile	IV	0.169	0.733	.003	8	view →
OV	DFS	Tertile	All	0.493	0.576	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

NDUFS5P3–STAD (OS)

Open the STAD breakdown →